{
    "xml": "<topic id=\"PHP445\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/pantoprazole\" basename=\"pantoprazole\" title=\"PANTOPRAZOLE\">\n<title>PANTOPRAZOLE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_754\" namespace=\"/interactions/list-of-drug-interactions/ulcer-healing-drugs/proton-pump-inhibitors/pantoprazole\">Pantoprazole</xref>\n</p>\n<data name=\"vtmid\">317317009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_104003650\" title=\"Proton pump inhibitors\">Proton pump inhibitors</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34658\" title=\"PROTON PUMP INHIBITORS\" namespace=\"/drug-classes/proton-pump-inhibitors\">PROTON PUMP INHIBITORS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP48634\" outputclass=\"indicationsAndDose\" rev=\"1.38\" parent=\"/drugs/pantoprazole\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">\n<ph outputclass=\"organism\">\n<i>Helicobacter pylori</i>\n</ph> eradication in combination with amoxicillin and clarithromycin; or in combination with clarithromycin and metronidazole</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;mg twice daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Benign gastric ulcer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;mg daily for 8 weeks; increased if necessary up to 80&#8239;mg daily, dose increased in severe cases.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Gastric ulcer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Duodenal ulcer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;mg daily for 4 weeks; increased if necessary up to 80&#8239;mg daily, dose increased in severe cases.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of NSAID-associated gastric ulcer in patients with an increased risk of gastroduodenal complications who require continued NSAID treatment</p>\n<p outputclass=\"therapeuticIndication\">Prophylaxis of NSAID-associated duodenal ulcer in patients with an increased risk of gastroduodenal complications who require continued NSAID treatment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>20&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Gastro-oesophageal reflux disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>20&#8211;80&#8239;mg daily for 4 weeks, continued for further 4 weeks if not fully healed, dose to be taken in the morning; maintenance 20&#8239;mg daily and increased to 40&#8239;mg daily, increased only if symptoms return.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Zollinger&#8211;Ellison syndrome (and other hypersecretory conditions)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 80&#8239;mg daily (max. per dose 80&#8239;mg), adjusted according to response.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>40&#8239;mg daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 80&#8239;mg, alternatively 160&#8239;mg in 2 divided doses, if rapid acid control required, then 80&#8239;mg once daily (max. per dose 80&#8239;mg), adjusted according to response.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48630\" outputclass=\"interactions\" rev=\"1.6\" parent=\"/drugs/pantoprazole\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (proton pump inhibitors).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48609\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/pantoprazole\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hyperlipidaemia</ph>; <ph outputclass=\"sideEffect\">weight changes</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48626\" outputclass=\"pregnancy\" parent=\"/drugs/pantoprazole\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;fetotoxic in <i>animals</i>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48741\" outputclass=\"breastFeeding\" parent=\"/drugs/pantoprazole\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;small amount present in milk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48682\" outputclass=\"hepaticImpairment\" parent=\"/drugs/pantoprazole\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Max. 20&#8239;mg daily in severe impairment and cirrhosis.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInHepaticImpairment\">\n<sectiondiv>\n<p>Monitor liver function in hepatic impairment (discontinue if deterioration).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48616\" outputclass=\"renalImpairment\" parent=\"/drugs/pantoprazole\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Max. oral dose 40&#8239;mg daily.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48771\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/drugs/pantoprazole\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>For<i>intravenous infusion</i> (<i>Protium</i>\n<sup>\n<tm tmtype=\"reg\"/>\n</sup>), give intermittently in Glucose 5% or Sodium chloride 0.9%; reconstitute 40&#8239;mg with 10&#8239;mL sodium chloride 0.9% and dilute with 100&#8239;mL of infusion fluid; give 40&#8239;mg over 15 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48556\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.8\" parent=\"/drugs/pantoprazole\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p>Pantoprazole 20&#8239;mg tablets can be sold to the public for the short-term treatment of reflux symptoms (e.g. heartburn) in adults over 18 years, max. daily dose 20&#8239;mg for max. 4 weeks.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP445-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/pantoprazole\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77886\" title=\"Gastro-resistant tablet\" namespace=\"/drugs/pantoprazole/gastro-resistant-tablet\">Gastro-resistant tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77936\" title=\"Powder for solution for injection\" namespace=\"/drugs/pantoprazole/powder-for-solution-for-injection\">Powder for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_754\" namespace=\"/interactions/list-of-drug-interactions/ulcer-healing-drugs/proton-pump-inhibitors/pantoprazole\" title=\"Pantoprazole\" count=\"1\" rel=\"link\">Pantoprazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34658\" namespace=\"/drug-classes/proton-pump-inhibitors\" title=\"PROTON PUMP INHIBITORS\" count=\"1\" rel=\"link\">PROTON PUMP INHIBITORS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77886\" namespace=\"/drugs/pantoprazole/gastro-resistant-tablet\" title=\"Gastro-resistant tablet\" count=\"1\" rel=\"link\">Gastro-resistant tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77936\" namespace=\"/drugs/pantoprazole/powder-for-solution-for-injection\" title=\"Powder for solution for injection\" count=\"1\" rel=\"link\">Powder for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP445",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/pantoprazole",
    "basename": "pantoprazole",
    "title": "PANTOPRAZOLE",
    "interactants": [
        {
            "id": "bnf_int_754",
            "label": "Pantoprazole"
        }
    ],
    "vtmid": "317317009",
    "drugClassification": [
        "Proton pump inhibitors"
    ],
    "inheritsFromClass": [
        "PROTON PUMP INHIBITORS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Helicobacter pylori eradication in combination with amoxicillin and clarithromycin; or in combination with clarithromycin and metronidazole",
                        "html": "<ph outputclass=\"organism\"> <i>Helicobacter pylori</i> </ph> eradication in combination with amoxicillin and clarithromycin; or in combination with clarithromycin and metronidazole",
                        "organism": "Helicobacter pylori"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "Helicobacter pylori"
                },
                "adult": [
                    {
                        "textContent": "40 mg twice daily.",
                        "html": "<p>40&#8239;mg twice daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Benign gastric ulcer",
                        "html": "Benign gastric ulcer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "40 mg daily for 8 weeks; increased if necessary up to 80 mg daily, dose increased in severe cases.",
                        "html": "<p>40&#8239;mg daily for 8 weeks; increased if necessary up to 80&#8239;mg daily, dose increased in severe cases.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Gastric ulcer",
                        "html": "Gastric ulcer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intravenous injection or by intravenous infusion",
                    "html": "By intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "40 mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.",
                        "html": "<p>40&#8239;mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Duodenal ulcer",
                        "html": "Duodenal ulcer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intravenous injection or by intravenous infusion",
                    "html": "By intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "40 mg daily for 4 weeks; increased if necessary up to 80 mg daily, dose increased in severe cases.",
                        "html": "<p>40&#8239;mg daily for 4 weeks; increased if necessary up to 80&#8239;mg daily, dose increased in severe cases.</p>"
                    },
                    {
                        "textContent": "40 mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.",
                        "html": "<p>40&#8239;mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of NSAID-associated gastric ulcer in patients with an increased risk of gastroduodenal complications who require continued NSAID treatment",
                        "html": "Prophylaxis of NSAID-associated gastric ulcer in patients with an increased risk of gastroduodenal complications who require continued NSAID treatment"
                    },
                    {
                        "textContent": "Prophylaxis of NSAID-associated duodenal ulcer in patients with an increased risk of gastroduodenal complications who require continued NSAID treatment",
                        "html": "Prophylaxis of NSAID-associated duodenal ulcer in patients with an increased risk of gastroduodenal complications who require continued NSAID treatment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "20 mg daily.",
                        "html": "<p>20&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Gastro-oesophageal reflux disease",
                        "html": "Gastro-oesophageal reflux disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intravenous injection or by intravenous infusion",
                    "html": "By intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "20&#8211;80 mg daily for 4 weeks, continued for further 4 weeks if not fully healed, dose to be taken in the morning; maintenance 20 mg daily and increased to 40 mg daily, increased only if symptoms return.",
                        "html": "<p>20&#8211;80&#8239;mg daily for 4 weeks, continued for further 4 weeks if not fully healed, dose to be taken in the morning; maintenance 20&#8239;mg daily and increased to 40&#8239;mg daily, increased only if symptoms return.</p>"
                    },
                    {
                        "textContent": "40 mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.",
                        "html": "<p>40&#8239;mg daily until oral administration can be resumed, injection to be given over at least 2 minutes.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Zollinger&#8211;Ellison syndrome (and other hypersecretory conditions)",
                        "html": "Zollinger&#8211;Ellison syndrome (and other hypersecretory conditions)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intravenous injection or by intravenous infusion",
                    "html": "By intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 80 mg daily (max. per dose 80 mg), adjusted according to response.",
                        "html": "<p>Initially 80&#8239;mg daily (max. per dose 80&#8239;mg), adjusted according to response.</p>"
                    },
                    {
                        "textContent": "40 mg daily.",
                        "html": "<p>40&#8239;mg daily.</p>",
                        "ageGroup": "elderly"
                    },
                    {
                        "textContent": "Initially 80 mg, alternatively 160 mg in 2 divided doses, if rapid acid control required, then 80 mg once daily (max. per dose 80 mg), adjusted according to response.",
                        "html": "<p>Initially 80&#8239;mg, alternatively 160&#8239;mg in 2 divided doses, if rapid acid control required, then 80&#8239;mg once daily (max. per dose 80&#8239;mg), adjusted according to response.</p>"
                    }
                ]
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (proton pump inhibitors).",
                "html": "<p>Appendix 1 (proton pump inhibitors).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Hyperlipidaemia",
                        "html": "Hyperlipidaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "weight changes",
                        "html": "weight changes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid unless potential benefit outweighs risk&#8212;fetotoxic in animals.",
                "html": "<p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;fetotoxic in <i>animals</i>.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid unless potential benefit outweighs risk&#8212;small amount present in milk.",
                "html": "<p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;small amount present in milk.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Max. 20 mg daily in severe impairment and cirrhosis.",
                "html": "<p>Max. 20&#8239;mg daily in severe impairment and cirrhosis.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Monitor liver function in hepatic impairment (discontinue if deterioration).",
                "html": "<p>Monitor liver function in hepatic impairment (discontinue if deterioration).</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Max. oral dose 40 mg daily.",
                "html": "<p>Max. oral dose 40&#8239;mg daily.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Forintravenous infusion (Protium ), give intermittently in Glucose 5% or Sodium chloride 0.9%; reconstitute 40 mg with 10 mL sodium chloride 0.9% and dilute with 100 mL of infusion fluid; give 40 mg over 15 minutes.",
                "html": "<p>For<i>intravenous infusion</i> (<i>Protium</i>\n<sup>\n<tm tmtype=\"reg\"/>\n</sup>), give intermittently in Glucose 5% or Sodium chloride 0.9%; reconstitute 40&#8239;mg with 10&#8239;mL sodium chloride 0.9% and dilute with 100&#8239;mL of infusion fluid; give 40&#8239;mg over 15 minutes.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "textContent": "Pantoprazole 20 mg tablets can be sold to the public for the short-term treatment of reflux symptoms (e.g. heartburn) in adults over 18 years, max. daily dose 20 mg for max. 4 weeks.",
                "html": "<p>Pantoprazole 20&#8239;mg tablets can be sold to the public for the short-term treatment of reflux symptoms (e.g. heartburn) in adults over 18 years, max. daily dose 20&#8239;mg for max. 4 weeks.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77886",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77936",
                "label": "Powder for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_754",
                "label": "Pantoprazole",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34658",
                "label": "PROTON PUMP INHIBITORS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77886",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77936",
                "label": "Powder for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}